跳至主要内容
临床试验/NCT01178437
NCT01178437已完成不适用

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy - a Prospective Pilot Study Regarding Safety, Effectiveness and Clinical Performance

cerbomed GmbH2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2009年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
7
试验地点
2
主要终点
Assessment of performance

研究概览

简要总结

The aim of the study is to prove the feasibility and safety of transcutaneous, electrical stimulation of the vagus nerve in patients with difficult-to-treat forms of epilepsy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written Informed Consent
  • Patients of both gender, aged from 18-75 years
  • Diagnosis of epilepsy according to the diagnosis criteria of the DSM IV/ ICD 10 (especially G 40.1 /G 40.2/ G 40.3)
  • Insufficient response to at least one attempt of treatment in medical history with anticonvulsive medication, dosed sufficiently long and high
  • Antiepileptic Drugs (AED) therapy must be stable at a level that promises long-term continuity for at least 10 before study start and has to be continued for at least 3 months during treatment phase

排除标准

  • Absence of Informed Consent
  • Pregnancy
  • Psychiatric diseases, especially post-traumatic stress disorder, obsessive-compulsive disorders, schizophrenia, Borderline personality disorders (BPD), character disorders as well as major depressive disorders, anxiety disorders and eating disorders as comorbidity.
  • Abuse of drugs and alcohol until 12 weeks before study start
  • Cerebrovascular diseases
  • Severe traumatic brain injury in medical history including invasive and non-invasive methods of therapy (tumor surgery, "Gamma Knife Surgery")
  • Indications of structural impairment of the basal ganglia or the brain stem
  • active implants (e.g. cochlea implants, VNS, pacemaker)
  • Severe neurological diseases (e.g. Morbus Parkinson, systemic neurologic diseases
  • severe internistic diseases (e.g. arterial hypertension, respiratory failure)
  • Bronchial asthma
  • malignant diseases of any kind, within five years before study start
  • Severe active infectious diseases (e.g. HIV, hepatitis)
  • Bone diseases (e.g. Morbus Paget, recent fractures)
  • Diseases of the ENT body system: Hearing loss of the left ear which is treated with a hearing instrument, all dermatologic and infectious diseases which affect the area around the pinna and the ear canal, severe malformation of the pinna
  • Concurrent participation in other studies
  • Other circumstances that in the opinion of the investigator might be an obstacle for enrolling the subject

结局指标

主要结局

Assessment of performance

时间窗: 9 months

rated by investigator QOLIE-89 MADRS CCTE

次要结局

  • Patient's subjective assessment of epileptic shocks(9 months)
  • Further assessment of performance(9 months)
  • Assessment of Safety(9 months)

研究者

发起方
cerbomed GmbH
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

Transcutaneous Non-invasive Stimulation of the Vagus... | 临床试验